Forbes January 23, 2025
A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.
Yesterday, the Trump Administration imposed a wide range of restrictions on the National Institutes of Health (NIH): a pause on all external communications, a hiring freeze, a travel ban and, perhaps most crucially, the cancellation of grant review panels, until at least February 1. These panels, where a team of NIH experts review research proposals, are required before the $47.4 billion agency will disburse money to support research by hospitals, universities and biotech companies.
The biggest chunk of this money goes toward cancer research. The NIH’s budget has a $7.1 billion annual budget for the...
Today's Sponsors
Today's Sponsor